BMRA Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for Biomerica Inc (BMRA.O) is 0.83, compared to its 5-year average forward P/E of 10.86. For a more detailed relative valuation and DCF analysis to assess Biomerica Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

10.86

Current PE

0.83

Overvalued PE

44.16

Undervalued PE

-22.44

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

1.01

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

3.90

Undervalued EV/EBITDA

-1.87

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

2.54

Current PS

0.29

Overvalued PS

4.92

Undervalued PS

0.16

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

BMRA News & Events

Events Timeline

No data

News

7.5

12-11Globenewswire

Biomerica Secures EDA Authorization for Multiple Cancer Screening Tests

7.5

12-11Newsfilter

Biomerica Receives EDA Authorization for Cancer Screening Tests in Egypt

9.0

12-11NASDAQ.COM

Biomerica Receives Approval in Egypt for Complete Range of Rapid Diagnostic Tests

People Also Watch

Frequently Asked Questions

What is Biomerica Inc (BMRA) stock price today?

The current price of BMRA is 2.5 USD — it has decreased -3.1 % in the last trading day.

What is Biomerica Inc (BMRA)'s business?

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.

What is the price predicton of BMRA Stock?

Wall Street analysts forecast BMRA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BMRA is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Biomerica Inc (BMRA)'s revenue for the last quarter?

Biomerica Inc revenue for the last quarter amounts to 1.38M USD, decreased -23.63 % YoY.

What is Biomerica Inc (BMRA)'s earnings per share (EPS) for the last quarter?

Biomerica Inc. EPS for the last quarter amounts to 0.00 USD, decreased -100.00 % YoY.

What changes have occurred in the market's expectations for Biomerica Inc (BMRA)'s fundamentals?

The market is revising No Change the revenue expectations for BMRA for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -16.39%.

How many employees does Biomerica Inc (BMRA). have?

Biomerica Inc (BMRA) has 53 emplpoyees as of December 15 2025.

What is Biomerica Inc (BMRA) market cap?

Today BMRA has the market capitalization of 7.61M USD.